Overview

Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the neurocognitive effects of brivaracetam
Phase:
Phase 1
Details
Lead Sponsor:
UCB Pharma
Treatments:
Brivaracetam
Etiracetam
Levetiracetam
Lorazepam
Piracetam